{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:25:32Z","timestamp":1787019932117,"version":"build-2736575974"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82174245"],"award-info":[{"award-number":["82174245"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82174017"],"award-info":[{"award-number":["82174017"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Biol Lett"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Drug resistance in metastatic lung cancer significantly contributes to patient mortality. This study explores the role of circulating tumor cells (CTCs), the precursors to metastasis, in driving this resistance. We aim to delineate the unique biological traits of CTC clusters in lung cancer and elucidate the mechanisms underlying their resistance to chemotherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We used an ultralow adsorption plate to establish a CTC suspension culture system. Comparisons between adherent and suspension cultures of CTC-TJH-01 cells were made via Cell Counting Kit-8 (CCK-8), western blot, immunofluorescence, and flow cytometry assays to evaluate cell proliferation, drug resistance, and cancer stemness. The tumorigenicity, tumor growth rate, and drug resistance of the CTC clusters were assessed in nude mice. Transcriptomic and proteomic analyses were subsequently conducted to identify differentially expressed genes and proteins in CTC-TJH-01 cells cultured under adherent and suspension conditions.\n                      <jats:italic>CDH17<\/jats:italic>\n                      gene knockdown in CTC-TJH-01 cells was achieved through RNA interference, and hematoxylin and eosin (HE) staining, immunohistochemistry, and immunofluorescence assays were used to examine the pathological status of these cells.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>CTC-TJH-01 cells in suspension formed cell clusters and exhibited decreased proliferation, tumorigenicity, and tumor growth, but increased cancer stemness and drug resistance. CDH17 protein expression was significantly upregulated in these clusters, activating the YAP\/TAZ pathway. Knocking down CDH17 not only inactivated this pathway but also significantly increased cell proliferation activity and cisplatin sensitivity in CTC-TJH-01 clusters. Additionally, the tumor growth rate was correlated with cisplatin sensitivity. CDH17 knockdown notably promoted the growth of CTC-TJH-01 xenografts and enhanced their sensitivity to cisplatin, although no significant difference was observed compared with those in the control group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The results indicate that lung CTC clusters with stem cell-like properties exhibit chemoresistance, which is linked to an activated CDH17-YAP pathway. Additionally, the effectiveness of cisplatin is primarily observed in tumors with relatively high growth rates, highlighting the connection between tumor growth and sensitivity to chemotherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s11658-025-00696-9","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T02:57:08Z","timestamp":1740365828000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Regulating chemoresistance and cancer stemness: the CDH17-YAP pathway in distinct cellular states of lung cancer CTC clusters"],"prefix":"10.1186","volume":"30","author":[{"given":"Zujun","family":"Que","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1680-3639","authenticated-orcid":false,"given":"Erxi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhui","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,24]]},"reference":[{"issue":"1","key":"696_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"696_CR2","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/j.cell.2023.03.003","volume":"186","author":"S Gerstberger","year":"2023","unstructured":"Gerstberger S, Jiang Q, Ganesh K. Metastasis. Cell. 2023;186(8):1564\u201379.","journal-title":"Cell"},{"issue":"11","key":"696_CR3","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41571-023-00815-5","volume":"20","author":"Y Pu","year":"2023","unstructured":"Pu Y, Li L, Peng H, Liu L, Heymann D, Robert C, et al. Drug-tolerant persister cells in cancer: the cutting edges and future directions. Nat Rev Clin Oncol. 2023;20(11):799\u2013813.","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"696_CR4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1056\/NEJMoa2304594","volume":"389","author":"M Tsuboi","year":"2023","unstructured":"Tsuboi M, Herbst RS, John T, Kato T, Majem M, Grohe C, et al. Overall survival with osimertinib in resected EGFR-mutated NSCLC. N Engl J Med. 2023;389(2):137\u201347.","journal-title":"N Engl J Med"},{"issue":"10308","key":"696_CR5","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/S0140-6736(21)02098-5","volume":"398","author":"E Felip","year":"2021","unstructured":"Felip E, Altorki N, Zhou C, Csoszi T, Vynnychenko I, Goloborodko O, et al. Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial. Lancet. 2021;398(10308):1344\u201357.","journal-title":"Lancet"},{"issue":"4","key":"696_CR6","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1056\/NEJMoa031644","volume":"350","author":"R Arriagada","year":"2004","unstructured":"Arriagada R, Bergman B, Dunant A, Le Chevalier T, Pignon JP, Vansteenkiste J, et al. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med. 2004;350(4):351\u201360.","journal-title":"N Engl J Med"},{"issue":"13","key":"696_CR7","first-page":"1583","volume":"136","author":"C Li","year":"2023","unstructured":"Li C, Lei S, Ding L, Xu Y, Wu X, Wang H, et al. Global burden and trends of lung cancer incidence and mortality. Chin Med J (Engl). 2023;136(13):1583\u201390.","journal-title":"Chin Med J (Engl)"},{"issue":"7","key":"696_CR8","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41571-023-00781-y","volume":"20","author":"R Lawrence","year":"2023","unstructured":"Lawrence R, Watters M, Davies CR, Pantel K, Lu YJ. Circulating tumour cells for early detection of clinically relevant cancer. Nat Rev Clin Oncol. 2023;20(7):487\u2013500.","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"696_CR9","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/crj.13601","volume":"17","author":"Y Xu","year":"2023","unstructured":"Xu Y, Li Q, Lin Z, Lin Y. The value of folate receptor-positive circulating tumor cells in the diagnosis of lung cancer and its correlation with clinical characteristics. Clin Respir J. 2023;17(5):374\u201383.","journal-title":"Clin Respir J"},{"issue":"1","key":"696_CR10","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1186\/s12885-023-10985-1","volume":"23","author":"Y Wang","year":"2023","unstructured":"Wang Y, Liu Y, Zhang Z, Lu B, Gao Y, Tong L, et al. Post-therapeutic circulating tumor cell-associated white blood cell clusters predict poor survival in patients with advanced driver gene-negative non-small cell lung cancer. BMC Cancer. 2023;23(1):578.","journal-title":"BMC Cancer"},{"issue":"9","key":"696_CR11","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1158\/2159-8290.CD-22-0644","volume":"13","author":"NK Dashzeveg","year":"2023","unstructured":"Dashzeveg NK, Jia Y, Zhang Y, Gerratana L, Patel P, Shajahan A, et al. Dynamic glycoprotein hyposialylation promotes chemotherapy evasion and metastatic seeding of quiescent circulating tumor cell clusters in breast cancer. Cancer Discov. 2023;13(9):2050\u201371.","journal-title":"Cancer Discov"},{"issue":"1","key":"696_CR12","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/s41467-022-28076-3","volume":"13","author":"L Borriello","year":"2022","unstructured":"Borriello L, Coste A, Traub B, Sharma VP, Karagiannis GS, Lin Y, et al. Primary tumor associated macrophages activate programs of invasion and dormancy in disseminating tumor cells. Nat Commun. 2022;13(1):626.","journal-title":"Nat Commun"},{"issue":"6","key":"696_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2023.188993","volume":"1878","author":"NM Abdelmaksoud","year":"2023","unstructured":"Abdelmaksoud NM, Abulsoud AI, Doghish AS, Abdelghany TM. From resistance to resilience: uncovering chemotherapeutic resistance mechanisms; insights from established models. Biochim Biophys Acta Rev Cancer. 2023;1878(6): 188993.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"1","key":"696_CR14","doi-asserted-by":"publisher","first-page":"11775","DOI":"10.1038\/s41598-023-38881-5","volume":"13","author":"J Seo","year":"2023","unstructured":"Seo J, Kumar M, Mason J, Blackhall F, Matsumoto N, Dive C, et al. Plasticity of circulating tumor cells in small cell lung cancer. Sci Rep. 2023;13(1):11775.","journal-title":"Sci Rep"},{"issue":"8","key":"696_CR15","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1038\/s41588-022-01141-9","volume":"54","author":"B Dalia","year":"2022","unstructured":"Dalia B, Reuben M, Maayan P, Deborah AL, Ian D, Gregor W, et al. Cancer cell states recur across tumor types and form specific interactions with the tumor microenvironment. Nat Genet. 2022;54(8):1192\u2013201.","journal-title":"Nat Genet"},{"issue":"1","key":"696_CR16","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13073-024-01309-4","volume":"16","author":"E Holton","year":"2024","unstructured":"Holton E, Muskovic W, Powell JE. Deciphering cancer cell state plasticity with single-cell genomics and artificial intelligence. Genome Med. 2024;16(1):36.","journal-title":"Genome Med"},{"issue":"1","key":"696_CR17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13046-024-02956-6","volume":"43","author":"RA Bartolome","year":"2024","unstructured":"Bartolome RA, Pintado-Berninches L, Martin-Regalado A, Robles J, Calvo-Lopez T, Ortega-Zapero M, et al. A complex of cadherin 17 with desmocollin 1 and p120-catenin regulates colorectal cancer migration and invasion according to the cell phenotype. J Exp Clin Cancer Res. 2024;43(1):31.","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"696_CR18","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1002\/jso.26399","volume":"123","author":"BH Zheng","year":"2021","unstructured":"Zheng BH, Shen S, Wong KF, Gong ZJ, Sun WT, Ni XJ, et al. Clinical correlation of cadherin-17 marker with advanced tumor stages and poor prognosis of cholangiocarcinoma. J Surg Oncol. 2021;123(5):1253\u201362.","journal-title":"J Surg Oncol"},{"issue":"4","key":"696_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.836","volume":"12","author":"Y Liu","year":"2022","unstructured":"Liu Y, Song Y, Cao M, Fan W, Cui Y, Cui Y, et al. A novel EHD1\/CD44\/Hippo\/SP1 positive feedback loop potentiates stemness and metastasis in lung adenocarcinoma. Clin Transl Med. 2022;12(4): e836.","journal-title":"Clin Transl Med"},{"issue":"5","key":"696_CR20","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1053\/j.gastro.2020.12.077","volume":"160","author":"M Liu","year":"2021","unstructured":"Liu M, Zhang Y, Yang J, Zhan H, Zhou Z, Jiang Y, et al. Zinc-dependent regulation of ZEB1 and YAP1 coactivation promotes epithelial\u2013mesenchymal transition plasticity and metastasis in pancreatic cancer. Gastroenterology. 2021;160(5):1771\u201383.","journal-title":"Gastroenterology"},{"issue":"12","key":"696_CR21","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3390\/ph13120430","volume":"13","author":"A Frtus","year":"2020","unstructured":"Frtus A, Smolkova B, Uzhytchak M, Lunova M, Jirsa M, Hof M, et al. Hepatic tumor cell morphology plasticity under physical constraints in 3D cultures driven by YAP-mTOR axis. Pharmaceuticals (Basel). 2020;13(12):430.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"12","key":"696_CR22","doi-asserted-by":"publisher","first-page":"3621","DOI":"10.1039\/C5AN02554K","volume":"141","author":"ZH Wang","year":"2016","unstructured":"Wang ZH, Wu WJ, Wang Z, Tang Y, Deng YL, Xu L, et al. Ex vivo expansion of circulating lung tumor cells based on one-step microfluidics-based immunomagnetic isolation. Analyst. 2016;141(12):3621\u20135.","journal-title":"Analyst"},{"key":"696_CR23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12935-019-0735-z","volume":"19","author":"ZJ Que","year":"2019","unstructured":"Que ZJ, Luo B, Zhou ZY, Dong CS, Jiang Y, Wang L, et al. Establishment and characterization of a patient-derived circulating lung tumor cell line in vitro and in vivo. Cancer Cell Int. 2019;19:21.","journal-title":"Cancer Cell Int"},{"key":"696_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.216011","volume":"554","author":"J Feng","year":"2023","unstructured":"Feng J, Xi Z, Jiang X, Li Y, Nik Nabil WN, Liu M, et al. Saikosaponin A enhances Docetaxel efficacy by selectively inducing death of dormant prostate cancer cells through excessive autophagy. Cancer Lett. 2023;554: 216011.","journal-title":"Cancer Lett"},{"key":"696_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.564833","volume":"11","author":"L Han","year":"2020","unstructured":"Han L, Xu D, Xi Z, Wu M, Nik Nabil WN, Zhang J, et al. The natural compound oblongifolin C exhibits anticancer activity by inhibiting HSPA8 and cathepsin B in vitro. Front Pharmacol. 2020;11: 564833.","journal-title":"Front Pharmacol"},{"issue":"5","key":"696_CR26","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/s41419-018-0574-1","volume":"9","author":"Y Li","year":"2018","unstructured":"Li Y, Xi Z, Chen X, Cai S, Liang C, Wang Z, et al. Natural compound Oblongifolin C confers gemcitabine resistance in pancreatic cancer by downregulating Src\/MAPK\/ERK pathways. Cell Death Dis. 2018;9(5):538.","journal-title":"Cell Death Dis"},{"key":"696_CR27","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.semcancer.2022.11.006","volume":"87","author":"W Guo","year":"2022","unstructured":"Guo W, Qiao T, Li T. The role of stem cells in small-cell lung cancer: evidence from chemoresistance to immunotherapy. Semin Cancer Biol. 2022;87:160\u20139.","journal-title":"Semin Cancer Biol"},{"issue":"6193","key":"696_CR28","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1126\/science.1253533","volume":"345","author":"M Yu","year":"2014","unstructured":"Yu M, Bardia A, Aceto N, Bersani F, Madden MW, Donaldson MC, et al. Cancer therapy. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility. Science. 2014;345(6193):216\u201320.","journal-title":"Science"},{"issue":"1\u20132","key":"696_CR29","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.cell.2018.11.046","volume":"176","author":"S Gkountela","year":"2019","unstructured":"Gkountela S, Castro-Giner F, Szczerba BM, Vetter M, Landin J, Scherrer R, et al. Circulating tumor cell clustering shapes DNA methylation to enable metastasis seeding. Cell. 2019;176(1\u20132):98-112e14.","journal-title":"Cell"},{"issue":"1","key":"696_CR30","doi-asserted-by":"publisher","first-page":"622","DOI":"10.18632\/oncotarget.23079","volume":"9","author":"JY Park","year":"2018","unstructured":"Park JY, Jeong AL, Joo HJ, Han S, Kim SH, Kim HY, et al. Development of suspension cell culture model to mimic circulating tumor cells. Oncotarget. 2018;9(1):622\u201340.","journal-title":"Oncotarget"},{"issue":"1","key":"696_CR31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12964-020-00627-5","volume":"19","author":"Y Li","year":"2021","unstructured":"Li Y, Wang Z, Ajani JA, Song S. Drug resistance and cancer stem cells. Cell Commun Signal. 2021;19(1):19.","journal-title":"Cell Commun Signal"},{"issue":"8","key":"696_CR32","doi-asserted-by":"publisher","first-page":"107302","DOI":"10.1016\/j.isci.2023.107302","volume":"26","author":"L Guo","year":"2023","unstructured":"Guo L, Mohanty A, Singhal S, Srivastava S, Nam A, Warden C, et al. Targeting ITGB4\/SOX2-driven lung cancer stem cells using proteasome inhibitors. iScience. 2023;26(8):107302.","journal-title":"iScience."},{"issue":"8022","key":"696_CR33","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/s41586-024-07690-9","volume":"631","author":"GS Franca","year":"2024","unstructured":"Franca GS, Baron M, King BR, Bossowski JP, Bjornberg A, Pour M, et al. Cellular adaptation to cancer therapy along a resistance continuum. Nature. 2024;631(8022):876\u201383.","journal-title":"Nature"},{"issue":"12","key":"696_CR34","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1016\/j.cell.2024.04.032","volume":"187","author":"SP Ayushi","year":"2024","unstructured":"Ayushi SP, Itai Y. A developmental constraint model of cancer cell states and tumor heterogeneity. Cell. 2024;187(12):2907\u201318.","journal-title":"Cell"},{"issue":"2","key":"696_CR35","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/PAP.0000000000000008","volume":"21","author":"NG Ordonez","year":"2014","unstructured":"Ordonez NG. Cadherin 17 is a novel diagnostic marker for adenocarcinomas of the digestive system. Adv Anat Pathol. 2014;21(2):131\u20137.","journal-title":"Adv Anat Pathol"},{"issue":"5","key":"696_CR36","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00408-023-00648-0","volume":"201","author":"W Tian","year":"2023","unstructured":"Tian W, Zhao J, Wang W. Targeting CDH17 with chimeric antigen receptor-redirected T cells in small cell lung cancer. Lung. 2023;201(5):489\u201397.","journal-title":"Lung"},{"issue":"5","key":"696_CR37","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/s43018-022-00344-7","volume":"3","author":"Z Feng","year":"2022","unstructured":"Feng Z, He X, Zhang X, Wu Y, Xing B, Knowles A, et al. Potent suppression of neuroendocrine tumors and gastrointestinal cancers by CDH17CAR T cells without toxicity to normal tissues. Nat Cancer. 2022;3(5):581\u201394.","journal-title":"Nat Cancer"},{"key":"696_CR38","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.canlet.2021.12.019","volume":"527","author":"Y Guo","year":"2022","unstructured":"Guo Y, Luo J, Zou H, Liu C, Deng L, Li P. Context-dependent transcriptional regulations of YAP\/TAZ in cancer. Cancer Lett. 2022;527:164\u201373.","journal-title":"Cancer Lett"},{"issue":"3","key":"696_CR39","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.cell.2011.04.009","volume":"145","author":"C Badouel","year":"2011","unstructured":"Badouel C, McNeill H. SnapShot: the hippo signaling pathway. Cell. 2011;145(3):484-e1.","journal-title":"Cell"},{"issue":"4","key":"696_CR40","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3390\/cells8040295","volume":"8","author":"CJ Lai","year":"2019","unstructured":"Lai CJ, Lin CY, Liao WY, Hour TC, Wang HD, Chuu CP. CD44 promotes migration and invasion of docetaxel-resistant prostate cancer cells likely via induction of hippo-yap signaling. Cells. 2019;8(4):295.","journal-title":"Cells"},{"key":"696_CR41","doi-asserted-by":"crossref","unstructured":"Liu J, Liu S, Tian J, Li J, Li M, Que Z. Lung metastases formed by disseminated tumor cells exhibit different proliferation states. Acta Biochim Biophys Sin (Shanghai). 2024.","DOI":"10.3724\/abbs.2024118"},{"issue":"11","key":"696_CR42","doi-asserted-by":"publisher","first-page":"27313","DOI":"10.3390\/ijms161126020","volume":"16","author":"X Zhang","year":"2015","unstructured":"Zhang X, de Milito A, Olofsson MH, Gullbo J, D\u2019Arcy P, Linder S. Targeting mitochondrial function to treat quiescent tumor cells in solid tumors. Int J Mol Sci. 2015;16(11):27313\u201326.","journal-title":"Int J Mol Sci"}],"container-title":["Cellular &amp; Molecular Biology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-025-00696-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11658-025-00696-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-025-00696-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T02:59:17Z","timestamp":1740365957000},"score":1,"resource":{"primary":{"URL":"https:\/\/cmbl.biomedcentral.com\/articles\/10.1186\/s11658-025-00696-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,24]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["696"],"URL":"https:\/\/doi.org\/10.1186\/s11658-025-00696-9","relation":{},"ISSN":["1689-1392"],"issn-type":[{"value":"1689-1392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,24]]},"assertion":[{"value":"24 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the animal experiments were approved by the Animal Ethical and Welfare Committee of Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine (approval number: 2020-0014; approval date 16 March 2020), in compliance with the guidelines of the Basel Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors reviewed this manuscript and approved the publication of this work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}